Download PDFPDF
IDDF2024-ABS-0157 Targeting tumor-intrinsic METTL5 reverses immune exclusion and enhances anti-PD-1 therapy efficacy in intrahepatic cholangiocarcinoma
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address